Levinus A. Dieleman

14.6k total citations · 3 hit papers
180 papers, 9.4k citations indexed

About

Levinus A. Dieleman is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Levinus A. Dieleman has authored 180 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Genetics, 75 papers in Epidemiology and 48 papers in Surgery. Recurrent topics in Levinus A. Dieleman's work include Inflammatory Bowel Disease (84 papers), Microscopic Colitis (63 papers) and Gut microbiota and health (41 papers). Levinus A. Dieleman is often cited by papers focused on Inflammatory Bowel Disease (84 papers), Microscopic Colitis (63 papers) and Gut microbiota and health (41 papers). Levinus A. Dieleman collaborates with scholars based in Canada, United States and Netherlands. Levinus A. Dieleman's co-authors include R. Balfour Sartor, Michael Schultz, Susan L. Tonkonogy, Rance K. Sellon, Richard N. Fedorak, Rosica Valcheva, E. P. van Rees, D Rennick, Mary Palmen and A. S. Peña and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Levinus A. Dieleman

173 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

1998 1.2k citations Susan L. Tonkonogy, Michael Schultz et al. profile →
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

1998 963 citations Levinus A. Dieleman, Mary Palmen et al. profile →
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice

1994 592 citations Levinus A. Dieleman et al. profile →

Peers

Countries citing papers authored by Levinus A. Dieleman

Since Specialization

Citations

This map shows the geographic impact of Levinus A. Dieleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levinus A. Dieleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levinus A. Dieleman more than expected).

Fields of papers citing papers by Levinus A. Dieleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levinus A. Dieleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levinus A. Dieleman. The network helps show where Levinus A. Dieleman may publish in the future.

Co-authorship network of co-authors of Levinus A. Dieleman

This figure shows the co-authorship network connecting the top 25 collaborators of Levinus A. Dieleman. A scholar is included among the top collaborators of Levinus A. Dieleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levinus A. Dieleman. Levinus A. Dieleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A73 MICROBIAL CONTRIBUTION TO THE RISK OF FUTURE CROHN’S DISEASE: STRATIFICATION BY SUBCLINICAL INFLAMMATION LEVELS MEASURED BY FECAL CALPROTECTIN 2025 ·Journal of the Canadian Association of Gastroenterology ·Quan Li, (unknown), (unknown), Meilan Xue, Anne M. Griffiths, Remo Panaccione, Levinus A. Dieleman, (unknown), Kerry L. Jacobson, Sang Lee, Kenneth Croitoru	1
2	Relating the molecular phenotype of ulcerative colitis to the clinical course 2025 ·Scientific Reports ·Katelynn S. Madill-Thomsen, Jeffery M. Venner, (unknown), Konrad S. Famulski, Aducio Thiesen, (unknown), Karen I. Kroeker, Karen Wong, Farhad Peerani, Levinus A. Dieleman, Frank Hoentjen, Daniel C. Baumgart, Philip F. Halloran, Brendan P. Halloran	1
3	ImmunoMet Oncogenesis: A New Concept to Understand the Molecular Drivers of Cancer 2025 ·Journal of Clinical Medicine ·(unknown), Sami El Khatib, Levinus A. Dieleman, Mohamed Salla, Shairaz Baksh	1
4	Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study 2024 ·Inflammatory Bowel Diseases ·Çharles N. Bernstein, Remo Panaccione, Zoann Nugent, Deborah A. Marshall, Gilaad G. Kaplan, Stephen Vanner, Levinus A. Dieleman, Lesley A. Graff, Anthony Otley, Jennifer Jones, Michelle Buresi, Sanjay K. Murthy, Mark Borgaonkar, Brian Bressler, Alain Bitton, Kenneth Croitoru, Sacha Sidani, Aida Fernandes, Paul Moayyedi	1
5	Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation 2023 ·International Journal of Molecular Sciences ·Mohamed Salla, Jimmy A. Guo, Harshad Joshi, Marilyn Gordon, (unknown), (unknown), (unknown), Heather Armstrong, Rosica Valcheva, Jason R.B. Dyck, Aducio Thiesen, Eytan Wine, Levinus A. Dieleman, Shairaz Baksh	10
6	Case report: Desmoid fibromatosis diagnosed in a 27-year-old male after being mistaken for a gastrointestinal stromal tumour 2022 ·Frontiers in Medicine ·(unknown), (unknown), Julinor Bacani, Cheryl Mather, (unknown), Levinus A. Dieleman	0
7	IMAGINE Network’s Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome 2020 ·BMJ Open ·Paul Moayyedi, Glenda MacQueen, Çharles N. Bernstein, Stephen Vanner, Přemysl Berčík, Karen Madsen, Michael G. Surette, John D. Rioux, Levinus A. Dieleman, Elena F. Verdú, Russell J. de Souza, Anthony Otley, Laura E. Targownik, John N. Lavis, Jennifer Cunningham, Deborah A. Marshall, Sandra Zelinsky, Aida Fernandes	11
8	Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels 2018 ·Gut Microbes ·Rosica Valcheva, Petya Koleva, Inés Martínez, Jens Walter, Michael G. Gänzle, Levinus A. Dieleman	153
9	Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort 2017 ·Alimentary Pharmacology & Therapeutics ·Christopher Ma, Richard N. Fedorak, Gilaad G. Kaplan, Levinus A. Dieleman, Shane Devlin, (unknown), Karen I. Kroeker, Cynthia H. Seow, Yvette Leung, Kerri L. Novak, Brendan P. Halloran, Vivian Huang, Karen Wong, Philip K. Blustein, Subrata Ghosh, Remo Panaccione	123
10	Increased Intestinal Permeability in Relatives of Patients With Crohn’s Disease Is Not Associated With Small Bowel Ulcerations 2017 ·Clinical Gastroenterology and Hepatology ·Christopher Teshima, Karen J. Goodman, (unknown), Samina A. Turk, Wael El‐Matary, Rosica Valcheva, (unknown), Marilyn Gordon, Peter Ho, (unknown), Daniel J. Wong, Dina Kao, Jonathan B. Meddings, Hien Q. Huynh, Levinus A. Dieleman	26
11	Recommendations for Probiotic Use—2015 Update 2015 ·Journal of Clinical Gastroenterology ·Martin H. Floch, W. Allan Walker, Mary Ellen Sanders, Max Nieuwdorp, Adam S. Kim, David A. Brenner, Amir Qamar, Tamir Miloh, Alfredo Guarino, Mario Guslandi, Levinus A. Dieleman, Yehuda Ringel, Eamonn M.M. Quigley, Lawrence J. Brandt	78
12	Probiotics in the Management of Ulcerative Colitis 2015 ·Journal of Clinical Gastroenterology ·Richa Chibbar, Levinus A. Dieleman	60
13	Environment and the Inflammatory Bowel Diseases 2013 ·SHILAP Revista de lepidopterología ·Alexandra Frolkis, Levinus A. Dieleman, Herman W. Barkema, Remo Panaccione, Subrata Ghosh, Richard N. Fedorak, Karen Madsen, Gilaad G. Kaplan	122
14	Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA 2012 ·PLoS ONE ·Naomi Hotte, Saad Y. Salim, (unknown), Eric J. Albert, Phil Bach, John Walker, Levinus A. Dieleman, Richard N. Fedorak, Karen Madsen	30
15	Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats 2012 ·PLoS ONE ·Xiaoxi B. Lin, Levinus A. Dieleman, (unknown), Ilona Bibova, Michael B. Sawyer, Hongyu Xue, Catherine J. Field, Vickie E. Baracos, Michael G. Gänzle	126
16	Probiotics in the Treatment of Human Inflammatory Bowel Diseases 2008 ·Journal of Clinical Gastroenterology ·Richard N. Fedorak, Levinus A. Dieleman	23
17	Are clinical outcomes in IBD improved by multidisciplinary clinics? 2008 ·Inflammatory Bowel Diseases ·(unknown), Levinus A. Dieleman	3
18	Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota 2007 ·Inflammatory Bowel Diseases ·Alexander Swidsinski, Beate C. Sydora, Yvonne Döerffel, Vera Loening‐Baucke, Mario Vaneechoutte, (unknown), J. Scholze, Herbert Lochs, Levinus A. Dieleman	119
19	Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice 2002 ·Inflammatory Bowel Diseases ·Michael Schultz, Claudia Veltkamp, Levinus A. Dieleman, (unknown), (unknown), Susan L. Tonkonogy, R. Balfour Sartor	290
20	Leukocyte migration in experimental inflammatory bowel disease 1997 ·Mediators of Inflammation ·E. P. van Rees, Mary Palmen, Frank R.W. van de Goot, B.A. Macher, Levinus A. Dieleman	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact